We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-0.67%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$17.5B
AUM Growth
+$1.25B
(+7.7%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
7.69%
Top 10 Holdings %
Top 10 Hldgs %
15.74%
Holding
691
New
246
Increased
140
Reduced
132
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$274M |
| 2 |
Apple
AAPL
|
+$233M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$200M |
| 4 |
Jabil
JBL
|
+$185M |
| 5 |
Zoom
ZM
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$269M |
| 2 |
Oracle
ORCL
|
+$215M |
| 3 |
Estee Lauder
EL
|
+$172M |
| 4 |
Dell
DELL
|
+$160M |
| 5 |
Microsoft
MSFT
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.54% |
| 2 | Consumer Discretionary | 14.14% |
| 3 | Healthcare | 13.6% |
| 4 | Industrials | 12.07% |
| 5 | Financials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Acumen Pharmaceuticals
ABOS
$173M
| $2.27M | 0.01% |
939,603
| – | – |
|
402
Achieve Life Sciences
ACHV
$693M
| $2.21M | 0.01% |
471,000
| – | – |
|
403
Annexon
ANNX
$895M
| $2.21M | 0.01% |
+450,000
| New | +$2.33M |
|
404
EyePoint Inc
EYPT
$1.18B
| $2.19M | 0.01% |
251,348
+103,511
| +70% | +$1.45M |
|
|
LAC
405
Lithium Americas
LAC
$1.18B
| $2.14M | 0.01% |
+800,000
| New | +$3.54M |
|
|
GRTS
406
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $2.14M | 0.01% |
+3,461,489
| New | +$2.92M |
|
407
Dorian LPG
LPG
$1.92B
| $2.1M | 0.01% |
+50,000
| New | +$2.15M |
|
408
CALL
Custom Truck One Source
CTOS
$2.39B
| $2.09M | 0.01% |
+479,592
| New | +$2.34M |
|
409
Verastem
VSTM
$607M
| $2.09M | 0.01% |
+700,000
| New | +$5.77M |
|
410
Rivian
RIVN
$23.2B
| $2.06M | 0.01% |
+153,600
| New | +$1.61M |
|
|
AUNA
411
Auna
AUNA
$387M
| $2M | 0.01% |
250,000
| – | – |
|
|
INN
412
Summit Hotel Properties
INN
$668M
| $1.97M | 0.01% |
+328,947
| New | +$2.01M |
|
413
Fortive
FTV
$18.5B
| $1.92M | 0.01% |
+34,400
| New | +$2M |
|
414
Evolus
EOLS
$495M
| $1.88M | 0.01% |
+173,586
| New | +$2.14M |
|
415
Kratos Defense & Security Solutions
KTOS
$11.6B
| $1.87M | 0.01% |
93,606
-425,000
| -82% | -$8.31M |
|
416
GCM Grosvenor
GCMG
$824M
| $1.86M | 0.01% |
191,053
| – | – |
|
|
SERV
417
Serve Robotics
SERV
$431M
| $1.8M | 0.01% |
+924,846
| New | +$2.49M |
|
|
MTAL
418
DELISTED
Metals Acquisition
MTAL
| $1.79M | 0.01% |
+130,902
| New | +$1.77M |
|
|
OLO
419
DELISTED
Olo Inc
OLO
| $1.77M | 0.01% |
+400,000
| New | +$1.89M |
|
420
CALL
SELLAS Life Sciences
SLS
$2.29B
| $1.76M | 0.01% |
1,479,067
+479,067
| +48% | +$652K |
|
421
Origin Bancorp
OBK
$1.65B
| $1.74M | 0.01% |
+54,985
| New | +$1.68M |
|
|
GB
422
DELISTED
Global Blue Group Holding
GB
| $1.74M | 0.01% |
360,114
-467,548
| -56% | -$2.33M |
|
423
Precision BioSciences
DTIL
$207M
| $1.72M | 0.01% |
176,382
-73,618
| -29% | -$867K |
|
424
GE Aerospace
GE
$382B
| $1.7M | 0.01% |
10,675
-616,393
| -98% | -$98.4M |
|
425
UroGen Pharma
URGN
$2.27B
| $1.68M | 0.01% |
+100,000
| New | +$1.42M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2024 Portfolio in Review
As of Q2 2024, Alyeska Investment Group held 691 positions worth $17.5B, up 7.7% from $16.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Alyeska Investment Group deployed $1.35B of net new capital in Q2 2024, opening 246 new positions and adding to 140 existing holdings. Its largest new stake was Qualcomm: 1,450,565 shares worth $289M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Oracle, an estimated $215M trimmed.
- Alyeska Investment Group's largest Q2 2024 buy was Qualcomm: 1,450,565 shares worth $289M.
- Alyeska Investment Group added most to Zoom in Q2 2024, an estimated $163M increase.
- Alyeska Investment Group's biggest Q2 2024 reduction was Oracle, cutting an estimated $215M.
- Alyeska Investment Group fully exited Alphabet (Google) Class A in Q2 2024, selling an estimated $269M.
- Alyeska Investment Group's ten largest holdings make up 16% of its $17.5B portfolio in Q2 2024.
- Alyeska Investment Group opened 246 new positions and closed 135 in Q2 2024.
- Alyeska Investment Group's portfolio value rose 7.7% quarter-over-quarter to $17.5B.
Based on Alyeska Investment Group's 13F filing for Q2 2024, filed 14 Aug 2024.